Patient and Provider Decision Making About HIV Postexposure Prophylaxis Following Sexual Violence: A Qualitative Analysis.

J Assoc Nurses AIDS Care

Jocelyn C. Anderson, PhD, RN, SANE-A, is an Assistant Professor, Ross and Carol Nese College of Nursing, Pennsylvania State University, University Park, Pennsylvania, USA. Michelle D. S. Boakye, PhD, MPH, RN, is a Postdoctoral Fellow, Fitzpatrick College of Nursing, Villanova University, Villanova, Pennsylvania, USA. Jessica Draughon Moret, PhD, RN, is an Associate Clinical Professor, Betty Irene Moore School of Nursing at UC Davis, Sacramento, California, USA.

Published: November 2023

To explore patient and health care provider HIV postexposure prophylaxis (PEP) decision making following sexual assault, semistructured interviews regarding HIV PEP provision with 15 patients and 10 health care providers were conducted. A qualitative, descriptive, thematic analysis approach was used. Four themes were derived: (a) medical concerns; (b) emotional, trauma, and support factors; (c) daily medication management; and (d) ensuring access to HIV PEP. How participants described these themes and the importance placed on factors within each theme varied between the two groups. Altering provider communication so that HIV PEP discussions better align with patient decision-making factors (e.g., trauma and ability to take in information, how to manage side effects) could facilitate improvement in HIV PEP decision making following sexual assault for patients. High-level policy changes would improve HIV PEP access for sexual assault patients without necessitating the extraordinary efforts individual providers currently undertake.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10592041PMC
http://dx.doi.org/10.1097/JNC.0000000000000430DOI Listing

Publication Analysis

Top Keywords

hiv pep
20
decision making
12
sexual assault
12
hiv postexposure
8
postexposure prophylaxis
8
health care
8
pep decision
8
making sexual
8
assault patients
8
hiv
7

Similar Publications

Background: Despite their ubiquity across sub-Saharan Africa, private pharmacies are underutilized for HIV service delivery beyond the sale of HIV self-test kits. To understand what uptake of HIV prevention and treatment services might look like if private pharmacies offered clients free HIV self-testing and referral to clinic-based HIV services, we conducted a pilot study in Kenya.

Methods: At 20 private pharmacies in Kisumu County, Kenya, pharmacy clients (≥ 18 years) purchasing sexual health-related products (e.

View Article and Find Full Text PDF

In this manuscript, we present a novel mathematical model for understanding the dynamics of HIV/AIDS and analyzing optimal control strategies. To capture the disease dynamics, we propose a new Caputo-Fabrizio fractional-order mathematical model denoted as SEIEUPIATR, where the exposed class is subdivided into two categories: exposed-identified EI and exposed-unidentified EU individuals. Exposed-identified individuals become aware of the disease within three days, while exposed-unidentified individuals remain unaware for more than three days.

View Article and Find Full Text PDF

Background: Bacterial sexually transmitted infections (STIs) continue to increase in the United States. Despite evidence of the effectiveness of doxycycline post-exposure prophylaxis (Doxy-PEP) to prevent STIs, little is known about providers' attitudes and willingness to implement Doxy-PEP.

Methods: An online questionnaire was sent to 575 clinical providers in New York State in September 2022.

View Article and Find Full Text PDF

Background: HIV remains a significant public health problem, particularly in Africa, where two-thirds of global cases occur. Nigeria is among the three countries with the highest burden. Despite free access to pre- and post-exposure prophylaxis (PrEP and PEP) in Nigerian hospitals, stigma, distance, and restrictive clinic hours hinder uptake, especially among vulnerable populations.

View Article and Find Full Text PDF

Unlabelled: The ResistAZM randomized controlled trial found that the receipt of ceftriaxone/azithromycin, compared to ceftriaxone was not associated with an increase in the proportion of oral commensal Neisseria spp. and streptococci with azithromycin resistance 14 days after treatment. We repeated the analyses by measuring the minimum inhibitory concentrations (MICs) of azithromycin and ceftriaxone for individual colonies of commensal Neisseria spp.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!